Abstract: A method for forming electrically conductive polyaniline (PANI)-based composites includes mixing a base form of PANI, a photo acid generator (PAG), and when the PAG does not hydrogen bond to the base form of PANI an additive which can form hydrogen bonds with the base form of PANI or PAG, together with at least one solvent to form a mixture. The solvent is removed from the mixture. After the removing, the mixture is photo-irradiated with a wavelength within an absorption band of the PAG for converting the base form of PANI to a salt form of PANI to form a polymer composite that includes the salt form of PANI. The polymer composite has a 25° C. electrical conductivity that is at least 3 orders of magnitude higher than a 25° C. electrical conductivity of the base form of PANI, such as a 25° C. electrical conductivity of ?0.01 S/cm.

Abstract: A portable electronic (200) device using a cover mechanism (100) to close off two or more interface holes (3512, 3522 and 353) is described. The portable electronic device includes a base portion (30). The cover mechanism includes a first cover member (50) and a second cover member (70). The first cover member has a first cover portion (51) to close off one or more interface holes. The second cover member has a second cover portion (71) to close off another one or more interface holes. The second cover member is latched to the base, and the first cover member is latched to the base and the second cover member.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO844, PRO1131 or PRO5992 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Abstract: A battery cover latch mechanism (10) used in portable electronic device (100) is described including a cover member (11), a housing member (12), a latch assembly (13), and a return member (14). The latch assembly slides from a released position to a latched position to latch the cover member to the housing member. The return member is secured to the cover member including an elastic sheet (141) secured to the latch assembly. The elastic sheet is used to return the latch assembly from the latched position to the released position.

Abstract: A battery cover latch mechanism (10) used in portable electronic device (100) is described including a cover member (113), a housing member (111), a latch member (1137), a pressing member (15), and a releasing member (17). The latch member is used to latch the cover member to the housing member. The releasing member can be elastic deformed such that the pressing member moves and deforms the releasing member to release the cover member from the housing member.

Abstract: A battery cover latching mechanism (20) used in a portable electronic device is described including a cover member (22) and a latch base (21). The latch base includes a first guiding rail (24) and a latching projection (218). The latch base defines a sliding groove (217) adjacent to the first guiding rail. The cover member can slide relative to the latch base and includes a second guiding rail (25) and a latching portion (23). The second guiding rail engages the first guiding rail. The latching portion is slidably received in the sliding groove. The first guiding rail guides the second guiding rail to slide along the guiding rail. The latching portion slides within the sliding groove and then latched by the latching projection.

Abstract: A key button structure (10) for using in a portable electronic device (100) is provided. The key button structure (10) include a housing (14) having a joining portion (1428) formed on the outer wall (1422) of the housing (14) and a key body (124) have a mating portion (1245) formed thereon corresponding with the joining portion (1428).

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO227, PRO233, PRO238, PRO1328, PRO4342, PRO7423, PRO10096, PRO21384, PRO353 or PRO1885 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Abstract: A protective cover mechanism for an interface opening of a portable electronic device includes a protective cover and a sliding member. The protective cover includes a cover body for covering the interface opening, and a shaft projecting from the cover body. The sliding member is engaged with the shaft of the protective cover so the cover body is rotatable relative to the sliding member to selectively cover or expose the interface opening.

Abstract: A housing assembly includes a main body, a protecting cover, a connecting rod, a first elastic element, and a second elastic element. The main body has a receiving groove. At least one interface is mounted on a bottom surface of the receiving groove. The first elastic element provides a force for driving a portion of the protecting cover away from the main body. The second elastic element provides a force for driving the connecting rod to move in the direction of pressing the connecting rod.

Abstract: A battery cover latching mechanism for a portable electronic device is described. The latching mechanism includes a latching member having a latching portion. The latching portion is resilient and can engage into a latching hole as the latching member is deformed from its original state to it deformed state and securely latched in the latching hole as the latching member is restored to its original state.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO218, PRO228, PRO271, PRO273, PRO295, PRO302, PRO305, PRO326, PRO386, PRO655, PRO162, PRO788, PRO792, PRO940, PRO941, PRO1004, PRO1012, PRO1016, PRO474, PRO5238, PRO1069, PRO1111, PRO1113, PRO1130, PRO1195, PRO1271, PRO1865, PRO1879, PRO3446, PRO3543, PRO4329, PRO4352, PRO5733, PRO9859, PRO9864, PRO9904, PRO9907, PRO10013, PRO90948, PRO28694, PRO16089, PRO19563, PRO19675, PRO20084, PRO21434, PRO50332, PRO38465 or PRO346 genes.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO226, PRO257, PRO268, PRO290, PRO36006, PRO363, PRO365, PRO382, PRO444, PRO705, PRO1071, PRO1125, PRO1134, PRO1155, PRO1281, PRO1343, PRO1379, PRO1380, PRO1387, PRO1419, PRO1433, PRO1474, PRO1550, PRO1571, PRO1572, PRO1759, PRO1904, PRO35193, PRO4341, PRO4348, PRO4369, PRO4381, PRO4407, PRO4425, PRO4985, PRO4989, PRO5737, PRO5800, PRO5993, PRO6017, PRO7174, PRO9744, PRO9821, PRO9852, PRO9873, PRO10196, PRO34778, PRO20233, PRO21956, PRO57290, PRO38465, PRO38683 or PRO85161 genes.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO196, PRO217, PRO231, PRO236, PRO245, PRO246, PRO258, PRO287, PRO328, PRO344, PRO357, PRO526, PRO724, PRO731, PRO732, PRO1003, PRO1104, PRO1151, PRO1244, PRO1298, PRO1313, PRO1570, PRO1886, PRO1891, PRO4409, PRO5725, PRO5994, PRO6097, PRO7425, PRO10102, PRO10282, PRO61709 or PRO779 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.

Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO179, PRO181, PRO244, PRO247, PRO269, PRO293, PRO298, PRO339, PRO341, PRO347, PRO531, PRO537, PRO718, PRO773, PRO860, PRO871, PRO872, PRO813, PRO828, PRO1100, PRO1114, PRO115, PRO1126, PRO1133, PRO1154, PRO1185, PRO1194, PRO1287, PRO1291, PRO1293, PRO1310, PRO1312, PRO1335, PRO1339, PRO2155, PRO1356, PRO1385, PRO1412, PRO1487, PRO1758, PRO1779, PRO1785, PRO1889, PRO90318, PRO3434, PRO3579, PRO4322, PRO4343, PRO4347, PRO4403, PRO4976, PRO260, PRO6014, PRO6027, PRO6181, PRO6714, PRO9922, PRO7179, PRO7476, PRO9824, PRO19814, PRO19836, PRO20088, PRO70789, PRO50298, PRO51592, PRO1757, PRO4421, PRO9903, PRO1106, PRO1411, PRO1486, PRO1565, PRO4399 or PRO4404 genes.